Ballentine Partners’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-100,000
| Closed | -$336K | – | 377 |
|
|
2018
Q3 | $336K | Hold |
100,000
| – | – | 0.02% | 248 |
|
|
2018
Q2 | $258K | Hold |
100,000
| – | – | 0.01% | 272 |
|
|
2018
Q1 | $220K | Hold |
100,000
| – | – | 0.01% | 313 |
|
|
2017
Q4 | $199K | Hold |
100,000
| – | – | 0.01% | 342 |
|
|
2017
Q3 | $324K | Hold |
100,000
| – | – | 0.02% | 251 |
|
|
2017
Q2 | $318K | Buy |
+100,000
| New | +$318K | 0.02% | 259 |
|
|
2013
Q3 | – | Sell |
-120,000
| Closed | -$499K | – | 141 |
|
|
2013
Q2 | $499K | Buy |
+120,000
| New | +$499K | 0.07% | 62 |
|